CN Stock MarketDetailed Quotes

000950 C.Q. Pharmaceutical Holding

Watchlist
  • 6.54
  • +0.48+7.92%
Market Closed Dec 20 15:00 CST
11.30BMarket Cap26.27P/E (TTM)

C.Q. Pharmaceutical Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-16.92%6.7B
3.33%6.77B
16.86%6.38B
23.26%9.15B
92.76%8.06B
26.83%6.56B
7.68%5.46B
31.03%7.42B
9.31%4.18B
58.84%5.17B
Transactional financial assets
----
----
----
----
-81.65%2M
-65.97%4.9M
-60.48%4.9M
-44.35%6.9M
-12.10%10.9M
-84.60%14.4M
Notes receivable and accounts receivable
1.00%35.84B
-2.52%36.07B
6.50%35.89B
15.38%33.33B
11.09%35.49B
25.71%37B
14.96%33.7B
9.63%28.89B
14.61%31.94B
9.30%29.44B
-Notes receivable
-22.29%299.73M
-0.50%363.48M
15.74%425.15M
5.63%429.76M
6.01%385.72M
2.20%365.3M
10.43%367.33M
11.02%406.85M
40.64%363.85M
44.41%357.43M
-Accounts receivable
1.26%35.54B
-2.54%35.71B
6.40%35.46B
15.52%32.9B
11.15%35.1B
26.00%36.64B
15.02%33.33B
9.61%28.48B
14.37%31.58B
8.97%29.08B
Other receivables (including interest and dividends)
-3.37%1.3B
-0.75%1.34B
-8.25%1.22B
5.11%1.19B
28.67%1.34B
36.43%1.35B
59.19%1.33B
31.46%1.13B
7.16%1.04B
9.31%988.88M
-Dividend receivable
----
--6.13M
----
----
--0
--0
--1.7M
--1.7M
--0
--41.81M
-Accrued interest receivable
----
----
----
----
----
----
----
----
--0
----
-Other receivable
----
-1.21%1.33B
----
----
----
42.45%1.35B
----
31.26%1.13B
--1.04B
4.69%947.07M
Advance payment
6.37%2.57B
13.05%2.73B
9.12%2.82B
-33.24%1.58B
22.65%2.42B
20.83%2.42B
66.59%2.58B
74.89%2.37B
48.08%1.97B
67.93%2B
Inventories
25.78%10.04B
25.42%9.05B
1.16%8.32B
0.79%7.92B
5.97%7.98B
13.59%7.21B
26.48%8.22B
29.94%7.86B
25.05%7.53B
7.13%6.35B
Receivable financing
-3.65%810.06M
49.63%950.48M
27.29%882.36M
51.47%1.11B
30.87%840.77M
-5.45%635.2M
75.34%693.21M
14.89%732.12M
26.26%642.44M
74.10%671.84M
Non-current assets due within one year
64.66%78.6M
36.09%64.97M
23.38%57.62M
56.23%75.32M
-64.53%47.74M
-64.38%47.74M
-58.30%46.7M
-69.41%48.21M
8,311.08%134.58M
752.42%134M
Other current assets
18.32%253.31M
0.17%199.79M
-16.25%241.42M
-11.84%214.91M
-19.31%214.09M
8.40%199.44M
59.63%288.25M
-1.06%243.78M
5.62%265.34M
-27.43%183.99M
Total current assets
2.12%57.59B
3.16%57.18B
6.65%55.81B
12.05%54.58B
18.16%56.4B
23.31%55.42B
19.01%52.33B
17.83%48.71B
16.98%47.73B
15.37%44.95B
Non Current assets
Other non-current financial assets
0.03%7.24M
0.03%7.24M
-46.43%7.23M
-88.53%7.23M
-93.83%7.23M
-94.38%7.23M
-89.60%13.5M
-67.89%63.06M
-13.54%117.22M
1.79%128.65M
Investment real estate
13.05%184.29M
11.09%184.84M
10.15%186.68M
11.03%191.55M
2.90%163.02M
0.80%166.39M
-2.02%169.47M
-2.61%172.51M
-9.85%158.43M
-6.60%165.07M
Long-term equity investment
3.97%3.16B
5.72%3.2B
4.14%3.17B
3.87%3.08B
4.25%3.04B
5.82%3.02B
7.45%3.04B
7.50%2.97B
12.82%2.92B
13.31%2.86B
Long term receivable account
19.90%437.6M
17.92%443.33M
72.27%461.72M
69.50%462.02M
31.61%364.98M
34.64%375.95M
-17.84%268.02M
-2.89%272.58M
-36.99%277.33M
-33.94%279.22M
Fixed assets
----
7.51%2.16B
----
----
----
19.30%2B
----
24.40%2.09B
----
15.12%1.68B
Fixed assets liquidation
----
43.06%167.65K
----
----
----
-2.98%117.19K
----
-56.42%150.15K
----
90.25%120.79K
Constru in process
----
-86.50%22.83M
----
----
----
-69.06%169.12M
----
-64.27%169.58M
----
29.35%546.62M
Intangible assets
27.82%331.39M
33.19%333.74M
26.33%322.75M
21.41%320.01M
2.23%259.26M
-1.00%250.59M
-0.83%255.48M
0.48%263.57M
2.32%253.6M
0.75%253.12M
Development expenditure
22.30%56.54M
16.29%56.22M
17.93%56.67M
24.90%58.88M
-11.35%46.23M
-3.28%48.34M
0.73%48.05M
3.15%47.14M
-11.58%52.15M
6.04%49.98M
Goodwill
-2.17%1.5B
-0.97%1.5B
-0.49%1.5B
-0.48%1.5B
-0.16%1.53B
3.79%1.52B
3.29%1.51B
3.28%1.51B
2.20%1.54B
-2.88%1.46B
Long deferred expense
18.12%128.02M
22.08%131.52M
17.45%113.6M
50.45%114.75M
65.39%108.37M
82.74%107.74M
66.07%96.72M
28.12%76.27M
-4.59%65.53M
-23.97%58.96M
Deferred tax assets
29.00%340.53M
33.95%339.41M
42.45%337.45M
45.65%328.69M
3.09%263.98M
-8.89%253.4M
-11.47%236.9M
-11.50%225.67M
6.71%256.07M
20.02%278.12M
Usufruct assets
10.31%432.39M
16.32%452.74M
18.22%466.18M
15.42%455.86M
-1.41%391.97M
3.40%389.22M
2.34%394.34M
-2.80%394.97M
11.40%397.59M
1.03%376.4M
Other non current assets
3.54%258.78M
-3.87%247.86M
9.64%248.01M
7.28%252.44M
-6.51%249.93M
-9.88%257.83M
-24.21%226.21M
-23.17%235.29M
-31.44%267.33M
-20.97%286.09M
Total non current assets
4.11%9.01B
5.87%9.07B
6.46%9.02B
5.47%8.95B
1.01%8.65B
1.78%8.57B
0.66%8.47B
1.44%8.48B
5.01%8.57B
5.58%8.42B
Total assets
2.39%66.6B
3.53%66.25B
6.62%64.82B
11.07%63.52B
15.55%65.05B
19.91%63.99B
16.06%60.8B
15.07%57.19B
14.98%56.3B
13.71%53.37B
Liabilities
Current liabilities
Short term loan
-8.64%14.06B
-14.16%13.79B
-7.97%13.9B
-6.13%13.87B
15.00%15.39B
26.74%16.07B
23.61%15.11B
23.38%14.77B
22.75%13.38B
22.90%12.68B
Transactional financial liabilities
--0
----
----
0.00%9.62M
0.00%9.62M
0.00%9.62M
0.00%9.62M
0.00%9.62M
-32.26%9.62M
-59.66%9.62M
Notes payable and accounts payable
15.76%19.27B
16.52%18.61B
15.65%18B
26.72%17.44B
16.37%16.65B
27.77%15.97B
29.74%15.56B
13.48%13.76B
17.91%14.3B
7.06%12.5B
-Notes payable
15.13%3.85B
39.23%3.53B
38.44%3.95B
46.15%4.03B
29.03%3.34B
8.67%2.53B
29.03%2.85B
0.84%2.76B
13.68%2.59B
8.05%2.33B
-Accounts payable
15.91%15.42B
12.24%15.08B
10.53%14.05B
21.85%13.41B
13.57%13.31B
32.15%13.44B
29.90%12.71B
17.16%11B
18.88%11.72B
6.83%10.17B
Contract liabilities
-2.11%686.01M
-16.86%623.44M
-34.93%618.69M
-37.48%447.73M
77.27%700.81M
176.31%749.83M
264.52%950.79M
232.28%716.16M
54.84%395.33M
20.61%271.38M
Salaries payable
5.43%111.26M
5.71%111.05M
-5.64%106.34M
3.98%160.77M
15.89%105.52M
24.44%105.05M
23.63%112.7M
4.85%154.61M
5.49%91.05M
3.49%84.42M
Taxs payable
-26.13%182.4M
-37.05%259.21M
-33.74%223.47M
-8.40%351.5M
-25.79%246.92M
27.12%411.78M
-4.09%337.25M
-4.13%383.75M
-11.66%332.72M
-11.55%323.92M
Other payable (including interest and dividends)
-7.51%6.01B
-6.43%6.21B
2.59%6.19B
26.98%6.76B
25.68%6.5B
27.30%6.64B
14.75%6.03B
1.90%5.32B
-6.62%5.17B
4.67%5.21B
-Dividend payable
8.32%81.89M
26.42%87.43M
25.63%78.48M
60.31%79.6M
60.89%75.6M
18.26%69.16M
66.61%62.47M
32.43%49.66M
-85.38%46.99M
-82.50%58.48M
-Other payable
----
-6.78%6.12B
----
----
----
27.41%6.57B
----
1.68%5.27B
----
10.94%5.15B
Non current liabilities due within one year
11.01%2.82B
-54.48%1.88B
-76.71%894.05M
-56.99%1.73B
-4.02%2.54B
189.90%4.14B
448.10%3.84B
580.46%4.02B
764.56%2.64B
277.75%1.43B
Other current liabilities
-39.14%1.53B
-4.77%2.13B
13.89%2.34B
36.65%2.1B
10.63%2.52B
-24.85%2.23B
-26.24%2.05B
48.07%1.54B
47.03%2.28B
93.82%2.97B
Total current liabilities
0.03%44.67B
-5.84%43.61B
-3.94%42.26B
5.37%42.86B
15.66%44.65B
30.56%46.32B
30.69%44B
28.21%40.67B
23.90%38.61B
19.94%35.48B
Current liabilities
Long term loan
36.99%3.46B
141.74%3.81B
173.35%3.6B
89.91%2.85B
-9.41%2.53B
-56.48%1.58B
-70.86%1.32B
-67.46%1.5B
-41.05%2.79B
-20.02%3.62B
Bonds payable
15.91%2B
24.28%2.2B
59.71%2.55B
-6.29%1.5B
7.86%1.72B
14.85%1.77B
5.70%1.6B
99.95%1.6B
165.61%1.6B
148.00%1.54B
Preferred stock
----
----
----
----
----
----
----
----
--0
----
Perpetual Debt
----
----
----
----
----
----
----
----
--0
----
Long term account payable
----
660.95%183.09M
----
----
----
-11.09%24.06M
----
-10.50%25.56M
----
-11.95%27.06M
Long term salaries pay
-4.39%47.84M
-4.03%49.91M
-4.10%51.07M
-3.80%53.6M
-4.57%50.03M
-4.47%52.01M
-4.17%53.25M
-3.72%55.72M
1.31%52.43M
1.55%54.44M
Specific account payable
----
----
----
----
----
----
----
----
----
--0
Deferred tax liabilities
31.58%51.82M
32.75%52.33M
33.99%52.9M
16.32%54.83M
-24.00%39.38M
-25.70%39.42M
-25.74%39.48M
-18.22%47.14M
104.80%51.82M
109.46%53.05M
Long term deferred income
-11.31%64.96M
-11.11%66.55M
-11.41%66.38M
-6.92%68.02M
-1.07%73.24M
-0.04%74.87M
-0.77%74.93M
-4.15%73.08M
-6.03%74.03M
-7.94%74.9M
Lease liabilities
11.41%277.76M
18.31%289.47M
19.64%290.14M
16.44%266.34M
-4.30%249.33M
2.42%244.67M
7.43%242.51M
1.07%228.74M
-27.01%260.52M
-35.88%238.89M
Other non current liabilities
7.16%281.57M
-14.28%266.35M
-14.82%272.57M
-2.33%271.76M
-5.57%262.75M
25.59%310.73M
-6.37%320M
-21.71%278.24M
-48.19%278.26M
-51.66%247.42M
Total non current liabilities
28.25%6.35B
69.08%6.92B
88.55%6.92B
35.43%5.16B
-3.48%4.95B
-30.17%4.09B
-46.08%3.67B
-38.69%3.81B
-19.99%5.13B
-6.32%5.86B
Total liabilities
2.85%51.02B
0.24%50.53B
3.18%49.19B
7.95%48.02B
13.41%49.61B
21.95%50.41B
17.78%47.67B
17.26%44.48B
16.41%43.74B
15.36%41.34B
Shareholders equity
Paid-in capital
0.00%1.73B
0.00%1.73B
-0.87%1.73B
-0.87%1.73B
-0.87%1.73B
-0.87%1.73B
0.00%1.74B
0.00%1.74B
0.00%1.74B
0.00%1.74B
Capital reserve funds
5.16%2.48B
5.79%2.49B
2.34%2.49B
2.35%2.49B
-3.30%2.36B
-3.31%2.36B
-0.00%2.44B
-0.01%2.44B
1.54%2.44B
1.65%2.44B
Surplus reserve funds
6.53%162.02M
6.53%162.02M
6.53%162.02M
6.53%162.02M
8.03%152.09M
8.03%152.09M
8.03%152.09M
8.03%152.09M
13.79%140.79M
13.79%140.79M
Retained profit
4.89%7.15B
2.59%7.1B
7.28%7.05B
8.45%6.95B
9.22%6.82B
17.98%6.92B
15.51%6.57B
14.85%6.41B
16.93%6.25B
15.09%5.87B
Less:Treasury stock
----
----
----
----
----
--0
0.00%41.9M
0.00%41.9M
0.00%41.9M
0.00%41.9M
Other composite income
-92.39%-87.01M
-93.22%-87.34M
-89.67%-86.79M
-89.67%-86.79M
-21.45%-45.23M
-21.38%-45.2M
-23.94%-45.76M
-23.94%-45.76M
16.93%-37.24M
16.93%-37.24M
Shareholders equity without minority interests
3.84%11.44B
2.55%11.4B
4.91%11.35B
5.58%11.25B
5.01%11.01B
9.93%11.11B
8.91%10.82B
8.46%10.65B
10.14%10.49B
8.98%10.11B
Minority interests
-6.43%4.15B
75.03%4.32B
85.86%4.29B
107.00%4.26B
114.11%4.43B
28.50%2.47B
16.69%2.31B
5.82%2.06B
10.95%2.07B
5.38%1.92B
Total shareholder equity
0.89%15.58B
15.72%15.72B
19.14%15.64B
22.01%15.51B
23.00%15.45B
12.90%13.58B
10.20%13.13B
8.02%12.71B
10.28%12.56B
8.39%12.03B
Total liabilityies and equity
2.39%66.6B
3.53%66.25B
6.62%64.82B
11.07%63.52B
15.55%65.05B
19.91%63.99B
16.06%60.8B
15.07%57.19B
14.98%56.3B
13.71%53.37B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianji International Accounting Firm (Special General Partnership)
--
--
--
Tianji International Accounting Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -16.92%6.7B3.33%6.77B16.86%6.38B23.26%9.15B92.76%8.06B26.83%6.56B7.68%5.46B31.03%7.42B9.31%4.18B58.84%5.17B
Transactional financial assets -----------------81.65%2M-65.97%4.9M-60.48%4.9M-44.35%6.9M-12.10%10.9M-84.60%14.4M
Notes receivable and accounts receivable 1.00%35.84B-2.52%36.07B6.50%35.89B15.38%33.33B11.09%35.49B25.71%37B14.96%33.7B9.63%28.89B14.61%31.94B9.30%29.44B
-Notes receivable -22.29%299.73M-0.50%363.48M15.74%425.15M5.63%429.76M6.01%385.72M2.20%365.3M10.43%367.33M11.02%406.85M40.64%363.85M44.41%357.43M
-Accounts receivable 1.26%35.54B-2.54%35.71B6.40%35.46B15.52%32.9B11.15%35.1B26.00%36.64B15.02%33.33B9.61%28.48B14.37%31.58B8.97%29.08B
Other receivables (including interest and dividends) -3.37%1.3B-0.75%1.34B-8.25%1.22B5.11%1.19B28.67%1.34B36.43%1.35B59.19%1.33B31.46%1.13B7.16%1.04B9.31%988.88M
-Dividend receivable ------6.13M----------0--0--1.7M--1.7M--0--41.81M
-Accrued interest receivable ----------------------------------0----
-Other receivable -----1.21%1.33B------------42.45%1.35B----31.26%1.13B--1.04B4.69%947.07M
Advance payment 6.37%2.57B13.05%2.73B9.12%2.82B-33.24%1.58B22.65%2.42B20.83%2.42B66.59%2.58B74.89%2.37B48.08%1.97B67.93%2B
Inventories 25.78%10.04B25.42%9.05B1.16%8.32B0.79%7.92B5.97%7.98B13.59%7.21B26.48%8.22B29.94%7.86B25.05%7.53B7.13%6.35B
Receivable financing -3.65%810.06M49.63%950.48M27.29%882.36M51.47%1.11B30.87%840.77M-5.45%635.2M75.34%693.21M14.89%732.12M26.26%642.44M74.10%671.84M
Non-current assets due within one year 64.66%78.6M36.09%64.97M23.38%57.62M56.23%75.32M-64.53%47.74M-64.38%47.74M-58.30%46.7M-69.41%48.21M8,311.08%134.58M752.42%134M
Other current assets 18.32%253.31M0.17%199.79M-16.25%241.42M-11.84%214.91M-19.31%214.09M8.40%199.44M59.63%288.25M-1.06%243.78M5.62%265.34M-27.43%183.99M
Total current assets 2.12%57.59B3.16%57.18B6.65%55.81B12.05%54.58B18.16%56.4B23.31%55.42B19.01%52.33B17.83%48.71B16.98%47.73B15.37%44.95B
Non Current assets
Other non-current financial assets 0.03%7.24M0.03%7.24M-46.43%7.23M-88.53%7.23M-93.83%7.23M-94.38%7.23M-89.60%13.5M-67.89%63.06M-13.54%117.22M1.79%128.65M
Investment real estate 13.05%184.29M11.09%184.84M10.15%186.68M11.03%191.55M2.90%163.02M0.80%166.39M-2.02%169.47M-2.61%172.51M-9.85%158.43M-6.60%165.07M
Long-term equity investment 3.97%3.16B5.72%3.2B4.14%3.17B3.87%3.08B4.25%3.04B5.82%3.02B7.45%3.04B7.50%2.97B12.82%2.92B13.31%2.86B
Long term receivable account 19.90%437.6M17.92%443.33M72.27%461.72M69.50%462.02M31.61%364.98M34.64%375.95M-17.84%268.02M-2.89%272.58M-36.99%277.33M-33.94%279.22M
Fixed assets ----7.51%2.16B------------19.30%2B----24.40%2.09B----15.12%1.68B
Fixed assets liquidation ----43.06%167.65K-------------2.98%117.19K-----56.42%150.15K----90.25%120.79K
Constru in process -----86.50%22.83M-------------69.06%169.12M-----64.27%169.58M----29.35%546.62M
Intangible assets 27.82%331.39M33.19%333.74M26.33%322.75M21.41%320.01M2.23%259.26M-1.00%250.59M-0.83%255.48M0.48%263.57M2.32%253.6M0.75%253.12M
Development expenditure 22.30%56.54M16.29%56.22M17.93%56.67M24.90%58.88M-11.35%46.23M-3.28%48.34M0.73%48.05M3.15%47.14M-11.58%52.15M6.04%49.98M
Goodwill -2.17%1.5B-0.97%1.5B-0.49%1.5B-0.48%1.5B-0.16%1.53B3.79%1.52B3.29%1.51B3.28%1.51B2.20%1.54B-2.88%1.46B
Long deferred expense 18.12%128.02M22.08%131.52M17.45%113.6M50.45%114.75M65.39%108.37M82.74%107.74M66.07%96.72M28.12%76.27M-4.59%65.53M-23.97%58.96M
Deferred tax assets 29.00%340.53M33.95%339.41M42.45%337.45M45.65%328.69M3.09%263.98M-8.89%253.4M-11.47%236.9M-11.50%225.67M6.71%256.07M20.02%278.12M
Usufruct assets 10.31%432.39M16.32%452.74M18.22%466.18M15.42%455.86M-1.41%391.97M3.40%389.22M2.34%394.34M-2.80%394.97M11.40%397.59M1.03%376.4M
Other non current assets 3.54%258.78M-3.87%247.86M9.64%248.01M7.28%252.44M-6.51%249.93M-9.88%257.83M-24.21%226.21M-23.17%235.29M-31.44%267.33M-20.97%286.09M
Total non current assets 4.11%9.01B5.87%9.07B6.46%9.02B5.47%8.95B1.01%8.65B1.78%8.57B0.66%8.47B1.44%8.48B5.01%8.57B5.58%8.42B
Total assets 2.39%66.6B3.53%66.25B6.62%64.82B11.07%63.52B15.55%65.05B19.91%63.99B16.06%60.8B15.07%57.19B14.98%56.3B13.71%53.37B
Liabilities
Current liabilities
Short term loan -8.64%14.06B-14.16%13.79B-7.97%13.9B-6.13%13.87B15.00%15.39B26.74%16.07B23.61%15.11B23.38%14.77B22.75%13.38B22.90%12.68B
Transactional financial liabilities --0--------0.00%9.62M0.00%9.62M0.00%9.62M0.00%9.62M0.00%9.62M-32.26%9.62M-59.66%9.62M
Notes payable and accounts payable 15.76%19.27B16.52%18.61B15.65%18B26.72%17.44B16.37%16.65B27.77%15.97B29.74%15.56B13.48%13.76B17.91%14.3B7.06%12.5B
-Notes payable 15.13%3.85B39.23%3.53B38.44%3.95B46.15%4.03B29.03%3.34B8.67%2.53B29.03%2.85B0.84%2.76B13.68%2.59B8.05%2.33B
-Accounts payable 15.91%15.42B12.24%15.08B10.53%14.05B21.85%13.41B13.57%13.31B32.15%13.44B29.90%12.71B17.16%11B18.88%11.72B6.83%10.17B
Contract liabilities -2.11%686.01M-16.86%623.44M-34.93%618.69M-37.48%447.73M77.27%700.81M176.31%749.83M264.52%950.79M232.28%716.16M54.84%395.33M20.61%271.38M
Salaries payable 5.43%111.26M5.71%111.05M-5.64%106.34M3.98%160.77M15.89%105.52M24.44%105.05M23.63%112.7M4.85%154.61M5.49%91.05M3.49%84.42M
Taxs payable -26.13%182.4M-37.05%259.21M-33.74%223.47M-8.40%351.5M-25.79%246.92M27.12%411.78M-4.09%337.25M-4.13%383.75M-11.66%332.72M-11.55%323.92M
Other payable (including interest and dividends) -7.51%6.01B-6.43%6.21B2.59%6.19B26.98%6.76B25.68%6.5B27.30%6.64B14.75%6.03B1.90%5.32B-6.62%5.17B4.67%5.21B
-Dividend payable 8.32%81.89M26.42%87.43M25.63%78.48M60.31%79.6M60.89%75.6M18.26%69.16M66.61%62.47M32.43%49.66M-85.38%46.99M-82.50%58.48M
-Other payable -----6.78%6.12B------------27.41%6.57B----1.68%5.27B----10.94%5.15B
Non current liabilities due within one year 11.01%2.82B-54.48%1.88B-76.71%894.05M-56.99%1.73B-4.02%2.54B189.90%4.14B448.10%3.84B580.46%4.02B764.56%2.64B277.75%1.43B
Other current liabilities -39.14%1.53B-4.77%2.13B13.89%2.34B36.65%2.1B10.63%2.52B-24.85%2.23B-26.24%2.05B48.07%1.54B47.03%2.28B93.82%2.97B
Total current liabilities 0.03%44.67B-5.84%43.61B-3.94%42.26B5.37%42.86B15.66%44.65B30.56%46.32B30.69%44B28.21%40.67B23.90%38.61B19.94%35.48B
Current liabilities
Long term loan 36.99%3.46B141.74%3.81B173.35%3.6B89.91%2.85B-9.41%2.53B-56.48%1.58B-70.86%1.32B-67.46%1.5B-41.05%2.79B-20.02%3.62B
Bonds payable 15.91%2B24.28%2.2B59.71%2.55B-6.29%1.5B7.86%1.72B14.85%1.77B5.70%1.6B99.95%1.6B165.61%1.6B148.00%1.54B
Preferred stock ----------------------------------0----
Perpetual Debt ----------------------------------0----
Long term account payable ----660.95%183.09M-------------11.09%24.06M-----10.50%25.56M-----11.95%27.06M
Long term salaries pay -4.39%47.84M-4.03%49.91M-4.10%51.07M-3.80%53.6M-4.57%50.03M-4.47%52.01M-4.17%53.25M-3.72%55.72M1.31%52.43M1.55%54.44M
Specific account payable --------------------------------------0
Deferred tax liabilities 31.58%51.82M32.75%52.33M33.99%52.9M16.32%54.83M-24.00%39.38M-25.70%39.42M-25.74%39.48M-18.22%47.14M104.80%51.82M109.46%53.05M
Long term deferred income -11.31%64.96M-11.11%66.55M-11.41%66.38M-6.92%68.02M-1.07%73.24M-0.04%74.87M-0.77%74.93M-4.15%73.08M-6.03%74.03M-7.94%74.9M
Lease liabilities 11.41%277.76M18.31%289.47M19.64%290.14M16.44%266.34M-4.30%249.33M2.42%244.67M7.43%242.51M1.07%228.74M-27.01%260.52M-35.88%238.89M
Other non current liabilities 7.16%281.57M-14.28%266.35M-14.82%272.57M-2.33%271.76M-5.57%262.75M25.59%310.73M-6.37%320M-21.71%278.24M-48.19%278.26M-51.66%247.42M
Total non current liabilities 28.25%6.35B69.08%6.92B88.55%6.92B35.43%5.16B-3.48%4.95B-30.17%4.09B-46.08%3.67B-38.69%3.81B-19.99%5.13B-6.32%5.86B
Total liabilities 2.85%51.02B0.24%50.53B3.18%49.19B7.95%48.02B13.41%49.61B21.95%50.41B17.78%47.67B17.26%44.48B16.41%43.74B15.36%41.34B
Shareholders equity
Paid-in capital 0.00%1.73B0.00%1.73B-0.87%1.73B-0.87%1.73B-0.87%1.73B-0.87%1.73B0.00%1.74B0.00%1.74B0.00%1.74B0.00%1.74B
Capital reserve funds 5.16%2.48B5.79%2.49B2.34%2.49B2.35%2.49B-3.30%2.36B-3.31%2.36B-0.00%2.44B-0.01%2.44B1.54%2.44B1.65%2.44B
Surplus reserve funds 6.53%162.02M6.53%162.02M6.53%162.02M6.53%162.02M8.03%152.09M8.03%152.09M8.03%152.09M8.03%152.09M13.79%140.79M13.79%140.79M
Retained profit 4.89%7.15B2.59%7.1B7.28%7.05B8.45%6.95B9.22%6.82B17.98%6.92B15.51%6.57B14.85%6.41B16.93%6.25B15.09%5.87B
Less:Treasury stock ----------------------00.00%41.9M0.00%41.9M0.00%41.9M0.00%41.9M
Other composite income -92.39%-87.01M-93.22%-87.34M-89.67%-86.79M-89.67%-86.79M-21.45%-45.23M-21.38%-45.2M-23.94%-45.76M-23.94%-45.76M16.93%-37.24M16.93%-37.24M
Shareholders equity without minority interests 3.84%11.44B2.55%11.4B4.91%11.35B5.58%11.25B5.01%11.01B9.93%11.11B8.91%10.82B8.46%10.65B10.14%10.49B8.98%10.11B
Minority interests -6.43%4.15B75.03%4.32B85.86%4.29B107.00%4.26B114.11%4.43B28.50%2.47B16.69%2.31B5.82%2.06B10.95%2.07B5.38%1.92B
Total shareholder equity 0.89%15.58B15.72%15.72B19.14%15.64B22.01%15.51B23.00%15.45B12.90%13.58B10.20%13.13B8.02%12.71B10.28%12.56B8.39%12.03B
Total liabilityies and equity 2.39%66.6B3.53%66.25B6.62%64.82B11.07%63.52B15.55%65.05B19.91%63.99B16.06%60.8B15.07%57.19B14.98%56.3B13.71%53.37B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianji International Accounting Firm (Special General Partnership)------Tianji International Accounting Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Superfungus
Superfungus
Intraday+1.17%
Traditional Chinese Medicine Concept
Traditional Chinese Medicine Concept
Intraday+0.82%
Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday+0.70%